SMMT
Summit Therapeutics PLC
16.50$
-3.9%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -878.6% | -1,910.3% | 638.7% | -145.3% | -61.5% | -62.0% | -5,619.2% | -2,974.4% | -5,812.4% | – | – | – | |
| 2.6% | 5.3% | 3.1% | 4.0% | 3.4% | 3.2% | 233.9% | 100.6% | 176.5% | – | – | – | |
| 76.7% | 129.0% | 72.5% | 16.1% | 11.0% | 1.3% | 206.3% | 524.7% | 1,670.1% | – | – | – | |
| 117.4% | 169.2% | 68.3% | 2.1% | 6.2% | 10.4% | 729.2% | 753.3% | 4,470.2% | – | – | – | |
| -39.5% | 82.3% | 1,674.6% | 48.9% | -96.1% | 2.2% | 72.3% | -2.7% | 1,379.2% | – | – | – | |
| 2.8% | 7.3% | 4.6% | 4.8% | 0.3% | 0.6% | 49.2% | 12.5% | 87.2% | – | – | – | |
| 1.3% | -4.0% | -4.2% | -52.4% | -0.6% | -0.3% | -49.2% | -12.5% | -87.2% | – | – | – | |
| – | 0.0% | 0.0% | 0.0% | 0.0% | – | – | – | – | – | – | – | |
| 1,634.3% | 78,064,012,490,242.0% | 42,087,542,087,542.1% | 7,058,159,232,072.3% | 0.0% | – | – | – | – | – | – | – | |
| -16.7% | 1.8% | 1.0% | -0.9% | -0.5% | -0.8% | 82,687.3% | 28,745.2% | 89,164.8% | – | – | – | |
| 1,614.3% | 2,461.0% | 21.7% | 137.4% | 78.0% | 77.0% | 5,904.2% | 3,192.8% | 86,699.0% | – | – | – | |
| 737.0% | 560.2% | 618.6% | -79.5% | 11.8% | 15.7% | 300.8% | 220.2% | 80,628.5% | – | – | – | |
| -881.4% | -1,917.6% | 634.1% | -150.0% | -61.8% | -36.8% | -5,668.4% | -2,986.9% | -5,899.6% | – | – | – |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.